The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors

被引：42

作者：

Strand, V

Hochberg, MC

机构：

[1] Stanford Univ, Palo Alto, CA 94304 USA

[2] Univ Maryland, Sch Med, Baltimore, MD 21201 USA

来源：

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2002年 / 47卷 / 04期

关键词：

D O I：

10.1002/art.10560

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：349 / 355

页数：7

共 50 条

[1] Risk of cardiovascular events and cyclooxygenase-2 inhibitors
Tabrizchi, Reza
VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (02) : 95 - 96
[2] Cardiovascular risk of selective cyclooxygenase-2 inhibitors
Schrör, K
Mehta, P
Mehta, JL
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2005, 10 (02) : 95 - 101
[3] Risk of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors in osteoarthritis
Cunnington, Marianne
Webb, David
Qizilbash, Nawab
Blum, David
Mander, Adrian
Funk, Michele Jonsson
Weil, John
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (06) : 601 - 608
[4] Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events
Mukherjee, D
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (05) : 817 - 821
[5] No change in risk with time of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors
Cunnington, Marianne
Webb, David
Qizilbash, Nawab
Blum, David
Mander, Adrian
Funk, Michelle
Weil, John
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S138 - S138
[6] Cyclooxygenase-2 inhibitors and cardiovascular risk
Solomon, Scott D.
CURRENT OPINION IN CARDIOLOGY, 2006, 21 (06) : 613 - 617
[7] Cyclooxygenase-2 inhibitors and cardiovascular thromboembolic events
White, WB
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (03) : 577 - 578
[8] Do cyclooxygenase inhibitors increase risk of cardiovascular thrombotic events?
Kvern, B
CANADIAN FAMILY PHYSICIAN, 2002, 48 : 1449 - 1451
[9] Cyclooxygenase-2 inhibitors and cardiovascular thromboembolic events - Reply
Bing, RJ
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (03) : 578 - 578
[10] Selective cyclooxygenase 2 inhibitors and cardiovascular events
Solomon, DH
ARTHRITIS AND RHEUMATISM, 2005, 52 (07): : 1968 - 1978

← 1 2 3 4 5 →